The Charcot-Marie-Tooth Association (CMTA) has given a $225,483 award to support the development of treatments for Charcot-Marie-Tooth disease…
Articles by Marisa Wexler, MS
The CMT Research Foundation (CMTRF) is joining forces with Nanite, a biotechnology company, to work toward the development…
Electrical stimulation reduced toxic PMP22 protein clumping and promoted myelin-making activity in a cell model of Charcot-Marie-Tooth disease type…
A novel mutation in the GJB1 gene was found to cause X-linked Charcot-Marie-Tooth disease (CMT) in a new study. “Our results…
A standardized tool called the Charcot–Marie–Tooth Examination Score (CMTES) help track disease progression in people with Charcot-Marie-Tooth disease (CMT)…
Blocking the activity of a protein known as SARM1 — called an “executioner” by scientists — may be a useful…
Weakness in the extremities, fatigue, and difficulty walking are typically the symptoms that affect people with Charcot–Marie–Tooth disease type…
The CMT Research Foundation (CMTRF) is teaming up with Oryzon Genomics to conduct preclinical testing of treatments that…
A never-before-reported mutation in the GJB1 gene was identified in a recent case report as the cause of X-linked Charcot-Marie-Tooth…
People with Charcot-Marie-Tooth disease (CMT) type 2 are likely to experience inefficient sleep with more time spent awake after…